Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2<sup>+</sup> breast cancer stem-like cells

Stanley Ly(The University of Texas MD Anderson Cancer Center), Venkata Lokesh Battula(The University of Texas MD Anderson Cancer Center)

Journal for ImmunoTherapy of Cancer

March 1, 2021

10.1136/jitc-2020-001197

Cited by 51

Related Papers

Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1

|Haematologica|2008|352

IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells

|Oncotarget|2017|34